Utama › Karsinoma Urotelial (Sel Transisi) › New York › Queens
Kajian klinikal Karsinoma Urotelial (Sel Transisi) di Queens, NY
15 kajian untuk Karsinoma Urotelial (Sel Transisi) sedang mencari peserta di lokasi dalam dan sekitar Queens (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- START New York Long Island LLC, Lake Success · 9 mi jauh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
DBC-664 in Adult Patients With Solid Tumors
Mengambil pesertaFasa 1
- START New York, Lake Success · 9 mi jauh
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Mengambil pesertaKajian pemerhatian
- The Feinstein Institutes for Medical Research, Lake Success · 9 mi jauh
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau, Rockville Centre · 10 mi jauh
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauh
A Study of GEN1106 in Participants With Solid Tumors
Mengambil pesertaFasa 1
- START New York Long Island LLC, Lake Success · 9 mi jauh
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Mengambil pesertaFasa 1
- NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola · 11 mi jauh
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Mengambil pesertaFasa 1/2
- START New York Long Island, New Hyde Park · 9 mi jauh
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Mengambil pesertaFasa 1/2
- Clinical Research Alliance, Inc, Westbury · 14 mi jauh
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Mengambil pesertaFasa 2
- MSK nassau, Uniondale · 13 mi jauh
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Mengambil pesertaFasa 1
- Start New York, LLC, Lake Success · 9 mi jauh
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Mengambil pesertaKajian pemerhatian
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi jauh
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Hempstead · 12 mi jauh
Kajian Karsinoma Urotelial (Sel Transisi) di bandar lain
- Nashville, TN23 kajian
- New York City, NY22 kajian
- Houston, TX19 kajian
- Dallas, TX18 kajian
- Edison, NJ18 kajian
- Los Angeles, CA17 kajian
- Chicago, IL14 kajian
- Arlington, VA12 kajian
- Boston, MA11 kajian
- San Antonio, TX11 kajian
- Austin, TX10 kajian
- Orange, CA10 kajian
Kajian lain di Queens
- Kanser Payudara64 kajian
- Kanser Paru-paru Bukan Sel Kecil49 kajian
- Kanser Kolorektal31 kajian
- Kanser Metastatik28 kajian
- Kanser Ovari28 kajian
- Kanser Prostat27 kajian
- Kanser (semua jenis)26 kajian
- Kanser Endometrium25 kajian
- Kanser Paru-paru22 kajian
- Leukemia Mieloid Akut21 kajian
- Mieloma Pelbagai20 kajian
- Kanser Pankreas20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.